Suppr超能文献

与生存边界处积极强化治疗相关的围产期因素:一项基于人群的研究。

Perinatal factors associated with active intensive treatment at the border of viability: a population-based study.

作者信息

Litmanovitz I, Reichman B, Arnon S, Boyko V, Lerner-Geva L, Bauer-Rusak S, Dolfin T

机构信息

Department of Neonatology, Meir Medical Center, Kfar Saba, Israel.

Department of Pediatrics, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

J Perinatol. 2015 Sep;35(9):705-11. doi: 10.1038/jp.2015.48. Epub 2015 May 14.

Abstract

OBJECTIVE

The aim of this national population-based study was to identify perinatal and neonatal factors associated with active intensive treatment (AIT) of infants born at the periviable period of 22 to 24 weeks of gestation.

STUDY DESIGN

Data from the Israel national very low-birth weight infant database on 2207 infants born alive in 1995 to 2010 at gestational age (GA) 22 to 24 weeks were evaluated. AIT was defined as endotracheal intubation in the delivery room or mechanical ventilation in the neonatal intensive care unit. Multivariable logistic regression analyses were used to identify the independent effect of demographic and perinatal factors on AIT for each gestational week.

RESULT

Of the 2207 infants born at 22 to 24 weeks GA, 1643 (74.4%) received AIT and 564 (25.6%) received comfort care. AIT increased from 25.5% at 22 weeks to 62.7 and 93.5% at 23 and 24 weeks GA, respectively, reflecting a 4.66 (95% confidence interval (CI) 3.32 to 6.54)- and 29.8 (95% CI 19.9 to 44.6)-fold odds for AIT at 23 and 24 weeks GA, respectively, compared with 22-week GA infants. Perinatal treatments associated with AIT included maternal tocolytic therapy (odds ratio (OR) 1.51, 95% CI 1.04 to 2.20), prenatal steroid therapy, both partial (OR 3.30, 95% CI 2.14 to 5.10) and complete (OR 3.17, 95% CI 1.91 to 5.26) and cesarean delivery (OR 2.68, 95% CI 1.88 to 3.83). Each unit increase in birth weight z-score was associated with an OR of 1.58 (95% CI 1.30 to 1.92) for AIT. At 22 weeks GA, maternal tocolytic treatment was associated with higher odds of AIT. In the 23 and 24-week GA infants, maternal infertility treatment, antenatal steroids, cesarean delivery and higher-birth weight z-scores were significantly associated with AIT. Among 23-week GA infants, AIT decreased significantly in the period 2006 to 2010 compared with 1995 to 2000 (OR 0.51, 95% CI 0.34 to 0.77).

CONCLUSION

An active approach in obstetric management of pregnancies appears to impact the neonatologists' decision to undertake AIT treatment in infants born at the border of viability. The higher odds for AIT associated with obstetric interventions might contribute to the reported beneficial effect of antenatal steroids and cesarean delivery on the survival of infants born at the border of viability.

摘要

目的

这项基于全国人口的研究旨在确定与妊娠22至24周可存活期出生婴儿的积极强化治疗(AIT)相关的围产期和新生儿因素。

研究设计

对以色列全国极低出生体重婴儿数据库中1995年至2010年出生时孕周(GA)为22至24周的2207例存活婴儿的数据进行评估。AIT定义为产房内气管插管或新生儿重症监护病房内机械通气。采用多变量逻辑回归分析确定每个孕周人口统计学和围产期因素对AIT的独立影响。

结果

在22至24周GA出生的2207例婴儿中,1643例(74.4%)接受了AIT,564例(25.6%)接受了舒适护理。AIT在22周时为25.5%,在23周和24周GA时分别增至62.7%和93.5%,与22周GA婴儿相比,23周和24周GA时AIT的优势比分别为4.66(95%置信区间(CI)3.32至6.54)和29.8(95%CI 19.9至44.6)倍。与AIT相关的围产期治疗包括母体宫缩抑制剂治疗(优势比(OR)1.51,95%CI 1.04至2.20)、产前类固醇治疗(部分治疗(OR 3.30,95%CI 2.14至5.10)和完全治疗(OR 3.17,95%CI 1.91至5.26))以及剖宫产(OR 2.68,95%CI 1.88至3.83)。出生体重z评分每增加一个单位,AIT的OR为1.58(95%CI 1.30至1.92)。在22周GA时,母体宫缩抑制剂治疗与AIT的较高几率相关。在23周和24周GA的婴儿中,母体不孕症治疗、产前类固醇、剖宫产和较高的出生体重z评分与AIT显著相关。在23周GA的婴儿中,与1995年至2000年相比,2006年至2010年期间AIT显著下降(OR 0.51,95%CI 0.34至0.77)。

结论

妊娠产科管理中的积极方法似乎会影响新生儿科医生对可存活期边缘出生婴儿进行AIT治疗的决定。与产科干预相关的AIT较高几率可能有助于产前类固醇和剖宫产对可存活期边缘出生婴儿存活的有益影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验